VARLILUMAB
UNII 0125DUV5XC

Substance Identification & Data

This profile provides standardized clinical and technical data for Varlilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0125DUV5XC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1393344-72-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0125DUV5XC

CAS Registry Number

1393344-72-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VARLILUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C99127

National Cancer Institute reference terminology for clinical and research data.

INN ID

9933

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-79

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Varlilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VARLILUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER

VARLILUMAB [INN]

VARLILUMAB [USAN]

VARLILUMAB [WHO-DD]